Susquehanna International Group
PEAR

Susquehanna International Group’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Susquehanna International Group’s Portfolio PEAR Stock Details PEAR Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
2023
Q1 		$7.69K Sell
2022
Q4 		$87.3K Buy
2022
Q3 		$42K Buy
2022
Q2 		– Sell
2022
Q1 		$388K Buy
2021
Q4 		– Sell
2021
Q3 		$767K Buy